Quick Answer

What causes prostate cancer?

Prostate cancer develops when genetic mutations cause prostate cells to grow uncontrollably. The exact trigger is not fully known, but age, genetics, race, hormonal factors, and environmental exposures significantly increase risk.

Understanding the Prostate and Cancer Development

The prostate is a small gland located below the bladder in men. It produces seminal fluid that nourishes and transports sperm.

Prostate cancer begins when normal prostate cells undergo DNA mutations. These mutations:

Disrupt normal cell growth control
Prevent natural cell death (apoptosis)
Trigger uncontrolled cell division

According to the National Cancer Institute (NCI), nearly all prostate cancers are adenocarcinomas, meaning they start in glandular cells.

What Causes Prostate Cancer at the Cellular Level?

1. DNA Mutations

Cancer begins with changes in DNA. These mutations may be:

Inherited (germline mutations)
Acquired over time (somatic mutations)

Mutations in genes such as BRCA1, BRCA2, and HOXB13 have been strongly associated with higher prostate cancer risk, as documented by the National Cancer Institute and American Cancer Society.

These mutations affect:

DNA repair mechanisms
Cell cycle regulation
Tumor suppression pathways

2. Hormonal Influence (Androgens)

Male hormones, especially testosterone and dihydrotestosterone (DHT), stimulate prostate cell growth.

The American Cancer Society confirms that prostate cancer cells depend on androgens for growth. This explains why advanced prostate cancer is often treated with androgen deprivation therapy.

Major Risk Factors for Prostate Cancer

While the exact cause remains unclear, several risk factors are well established.

Age

Risk increases significantly after age 50
Most cases occur in men over 65

The Centers for Disease Control and Prevention (CDC) confirms age as the strongest risk factor.

Family History and Genetics

Men with:

A father or brother diagnosed with prostate cancer
Multiple affected relatives
Early-onset family cases

have significantly higher risk.

The National Comprehensive Cancer Network (NCCN) recommends genetic counseling for men with strong family history.

Race and Ethnicity

According to the CDC and American Cancer Society:

African American men have the highest incidence
They are more likely to develop aggressive disease
Mortality rates are higher compared to other racial groups

The biological reasons remain under investigation.

Obesity and Metabolic Health

Research published in The Journal of Clinical Oncology shows obesity is linked with:

Higher risk of aggressive prostate cancer
Increased risk of recurrence

Excess body fat may alter hormone levels and increase inflammation.

Diet and Environmental Factors

Evidence suggests:

High consumption of processed red meat may increase risk
Low intake of vegetables may reduce protective antioxidants
Long-term exposure to certain industrial chemicals may contribute

However, dietary causes remain under active research and are not considered definitive.

Is Prostate Cancer Caused by Lifestyle Alone?

No. While lifestyle factors influence risk, prostate cancer is not caused by one behavior alone.

The Mayo Clinic emphasizes that many men with healthy lifestyles still develop prostate cancer, while others with risk factors do not.

Cancer development is multifactorial:

Genetic predisposition
Hormonal exposure
Aging-related DNA damage
Environmental influences

Inflammation and Prostate Cancer

Chronic inflammation of the prostate (prostatitis) has been studied as a possible contributor.

The National Cancer Institute reports that chronic inflammation may:

Promote DNA damage
Encourage tumor microenvironment changes

However, inflammation is not considered a direct cause, but rather a possible contributing factor.

Environmental and Occupational Exposures

Some studies link prostate cancer to:

Agent Orange exposure (Vietnam veterans)
Certain agricultural chemicals
Industrial toxins

The U.S. Department of Veterans Affairs recognizes prostate cancer as associated with Agent Orange exposure.

Evidence for other toxins remains under investigation.

Unique Clinical Takeaways

1. Genetic Testing Should Be Risk-Stratified, Not Universal

Men with:

Family history of breast, ovarian, or pancreatic cancer
Known BRCA mutations in relatives
Early-onset prostate cancer in family

should undergo genetic evaluation.

This approach helps:

Identify high-risk individuals
Guide early screening
Inform targeted therapy options

Blind screening without risk stratification may cause unnecessary anxiety and overtreatment.

2. Aggressiveness Varies — Not All Prostate Cancer Is Dangerous

One major clinical insight is that prostate cancer ranges from:

Slow-growing, indolent tumors
Highly aggressive metastatic disease

The National Cancer Institute confirms many prostate cancers grow slowly and may not require immediate treatment.

This impacts clinical decisions:

Active surveillance is often appropriate
Overdiagnosis can lead to unnecessary procedures
PSA screening decisions must be individualized

Understanding this distinction prevents overtreatment.

3. Hormone Sensitivity Defines Treatment Pathways

Unlike many cancers, prostate cancer is highly hormone-dependent.

Advanced prostate cancer treatment focuses on:

Lowering testosterone
Blocking androgen receptors
Preventing hormone synthesis

This biological feature directly connects cause and treatment.

Patients with castration-resistant prostate cancer show adaptation at the cellular level, meaning tumor biology evolves. Monitoring hormone response becomes critical.

4. Racial Disparities Reflect Both Biology and Access

Higher mortality in African American men involves:

Potential genetic differences
Tumor biology variations
Screening access disparities
Healthcare access limitations

According to the American Cancer Society, earlier and more aggressive screening strategies may be appropriate in high-risk populations.

Clinical management must account for both biological and systemic factors.

5. PSA Elevation Does Not Equal Cancer

Prostate-specific antigen (PSA) rises due to:

Benign prostatic hyperplasia (BPH)
Prostatitis
Urinary infection
Recent ejaculation

Differential diagnosis is essential.

The U.S. Preventive Services Task Force (USPSTF) recommends shared decision-making for PSA screening in men aged 55–69.

Elevated PSA alone does not confirm cancer.

Can Prostate Cancer Be Prevented?

There is no guaranteed prevention strategy.

However, evidence supports:

Maintaining healthy body weight
Regular physical activity
Balanced diet rich in fruits and vegetables
Avoiding smoking

The American Cancer Society notes these measures support overall health but do not eliminate risk.

Early Detection and Screening

PSA Test

Measures prostate-specific antigen levels in blood.

Digital Rectal Exam (DRE)

Physical examination of the prostate.

Screening recommendations vary. The USPSTF advises individualized decisions after physician discussion.

Men over 70 are generally not recommended for routine screening unless high risk.

Summary

What causes prostate cancer?

Genetic mutations initiate abnormal cell growth
Age is the strongest risk factor
Family history significantly increases risk
Hormonal exposure influences tumor growth
Race and obesity modify disease behavior

There is no single cause. Prostate cancer results from a complex interaction of genetic, hormonal, and environmental factors.

References and Citations

Internal clinical reference materials and guidelines reviewed from:

National Cancer Institute – Prostate Cancer Overview
American Cancer Society – Prostate Cancer Risk Factors
Centers for Disease Control and Prevention – Prostate Cancer Data
National Comprehensive Cancer Network (NCCN) Guidelines
U.S. Preventive Services Task Force – PSA Screening Recommendations
Mayo Clinic – Prostate Cancer Causes and Risk Factors
Journal of Clinical Oncology – Obesity and Aggressive Prostate Cancer

Medical Disclaimer

This article is for educational purposes only and does not substitute professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider regarding medical concerns.